Cargando…

Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study

INTRODUCTION: Our goal was to assess the effects of titration of a norepinephrine infusion to increasing levels of mean arterial pressure (MAP) on sublingual microcirculation. METHODS: Twenty septic shock patients were prospectively studied in two teaching intensive care units. The patients were mec...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubin, Arnaldo, Pozo, Mario O, Casabella, Christian A, Pálizas, Fernando, Murias, Gastón, Moseinco, Miriam C, Kanoore Edul, Vanina S, Estenssoro, Elisa, Ince, Can
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717464/
https://www.ncbi.nlm.nih.gov/pubmed/19534818
http://dx.doi.org/10.1186/cc7922
_version_ 1782169904722477056
author Dubin, Arnaldo
Pozo, Mario O
Casabella, Christian A
Pálizas, Fernando
Murias, Gastón
Moseinco, Miriam C
Kanoore Edul, Vanina S
Pálizas, Fernando
Estenssoro, Elisa
Ince, Can
author_facet Dubin, Arnaldo
Pozo, Mario O
Casabella, Christian A
Pálizas, Fernando
Murias, Gastón
Moseinco, Miriam C
Kanoore Edul, Vanina S
Pálizas, Fernando
Estenssoro, Elisa
Ince, Can
author_sort Dubin, Arnaldo
collection PubMed
description INTRODUCTION: Our goal was to assess the effects of titration of a norepinephrine infusion to increasing levels of mean arterial pressure (MAP) on sublingual microcirculation. METHODS: Twenty septic shock patients were prospectively studied in two teaching intensive care units. The patients were mechanically ventilated and required norepinephrine to maintain a mean arterial pressure (MAP) of 65 mmHg. We measured systemic hemodynamics, oxygen transport and consumption (DO(2 )and VO(2)), lactate, albumin-corrected anion gap, and gastric intramucosal-arterial PCO(2 )difference (ΔPCO(2)). Sublingual microcirculation was evaluated by sidestream darkfield (SDF) imaging. After basal measurements at a MAP of 65 mmHg, norepinephrine was titrated to reach a MAP of 75 mmHg, and then to 85 mmHg. Data were analyzed using repeated measurements ANOVA and Dunnett test. Linear trends between the different variables and increasing levels of MAP were calculated. RESULTS: Increasing doses of norepinephrine reached the target values of MAP. The cardiac index, pulmonary pressures, systemic vascular resistance, and left and right ventricular stroke work indexes increased as norepinephrine infusion was augmented. Heart rate, DO(2 )and VO(2), lactate, albumin-corrected anion gap, and ΔPCO(2 )remained unchanged. There were no changes in sublingual capillary microvascular flow index (2.1 ± 0.7, 2.2 ± 0.7, 2.0 ± 0.8) and the percent of perfused capillaries (72 ± 26, 71 ± 27, 67 ± 32%) for MAP values of 65, 75, and 85 mmHg, respectively. There was, however, a trend to decreased capillary perfused density (18 ± 10,17 ± 10,14 ± 2 vessels/mm(2), respectively, ANOVA P = 0.09, linear trend P = 0.045). In addition, the changes of perfused capillary density at increasing MAP were inversely correlated with the basal perfused capillary density (R(2 )= 0.95, P < 0.0001). CONCLUSIONS: Patients with septic shock showed severe sublingual microcirculatory alterations that failed to improve with the increases in MAP with norepinephrine. Nevertheless, there was a considerable interindividual variation. Our results suggest that the increase in MAP above 65 mmHg is not an adequate approach to improve microcirculatory perfusion and might be harmful in some patients.
format Text
id pubmed-2717464
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27174642009-07-29 Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study Dubin, Arnaldo Pozo, Mario O Casabella, Christian A Pálizas, Fernando Murias, Gastón Moseinco, Miriam C Kanoore Edul, Vanina S Pálizas, Fernando Estenssoro, Elisa Ince, Can Crit Care Research INTRODUCTION: Our goal was to assess the effects of titration of a norepinephrine infusion to increasing levels of mean arterial pressure (MAP) on sublingual microcirculation. METHODS: Twenty septic shock patients were prospectively studied in two teaching intensive care units. The patients were mechanically ventilated and required norepinephrine to maintain a mean arterial pressure (MAP) of 65 mmHg. We measured systemic hemodynamics, oxygen transport and consumption (DO(2 )and VO(2)), lactate, albumin-corrected anion gap, and gastric intramucosal-arterial PCO(2 )difference (ΔPCO(2)). Sublingual microcirculation was evaluated by sidestream darkfield (SDF) imaging. After basal measurements at a MAP of 65 mmHg, norepinephrine was titrated to reach a MAP of 75 mmHg, and then to 85 mmHg. Data were analyzed using repeated measurements ANOVA and Dunnett test. Linear trends between the different variables and increasing levels of MAP were calculated. RESULTS: Increasing doses of norepinephrine reached the target values of MAP. The cardiac index, pulmonary pressures, systemic vascular resistance, and left and right ventricular stroke work indexes increased as norepinephrine infusion was augmented. Heart rate, DO(2 )and VO(2), lactate, albumin-corrected anion gap, and ΔPCO(2 )remained unchanged. There were no changes in sublingual capillary microvascular flow index (2.1 ± 0.7, 2.2 ± 0.7, 2.0 ± 0.8) and the percent of perfused capillaries (72 ± 26, 71 ± 27, 67 ± 32%) for MAP values of 65, 75, and 85 mmHg, respectively. There was, however, a trend to decreased capillary perfused density (18 ± 10,17 ± 10,14 ± 2 vessels/mm(2), respectively, ANOVA P = 0.09, linear trend P = 0.045). In addition, the changes of perfused capillary density at increasing MAP were inversely correlated with the basal perfused capillary density (R(2 )= 0.95, P < 0.0001). CONCLUSIONS: Patients with septic shock showed severe sublingual microcirculatory alterations that failed to improve with the increases in MAP with norepinephrine. Nevertheless, there was a considerable interindividual variation. Our results suggest that the increase in MAP above 65 mmHg is not an adequate approach to improve microcirculatory perfusion and might be harmful in some patients. BioMed Central 2009 2009-06-17 /pmc/articles/PMC2717464/ /pubmed/19534818 http://dx.doi.org/10.1186/cc7922 Text en Copyright © 2009 Dubin et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Dubin, Arnaldo
Pozo, Mario O
Casabella, Christian A
Pálizas, Fernando
Murias, Gastón
Moseinco, Miriam C
Kanoore Edul, Vanina S
Pálizas, Fernando
Estenssoro, Elisa
Ince, Can
Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study
title Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study
title_full Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study
title_fullStr Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study
title_full_unstemmed Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study
title_short Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study
title_sort increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717464/
https://www.ncbi.nlm.nih.gov/pubmed/19534818
http://dx.doi.org/10.1186/cc7922
work_keys_str_mv AT dubinarnaldo increasingarterialbloodpressurewithnorepinephrinedoesnotimprovemicrocirculatorybloodflowaprospectivestudy
AT pozomarioo increasingarterialbloodpressurewithnorepinephrinedoesnotimprovemicrocirculatorybloodflowaprospectivestudy
AT casabellachristiana increasingarterialbloodpressurewithnorepinephrinedoesnotimprovemicrocirculatorybloodflowaprospectivestudy
AT palizasfernando increasingarterialbloodpressurewithnorepinephrinedoesnotimprovemicrocirculatorybloodflowaprospectivestudy
AT muriasgaston increasingarterialbloodpressurewithnorepinephrinedoesnotimprovemicrocirculatorybloodflowaprospectivestudy
AT moseincomiriamc increasingarterialbloodpressurewithnorepinephrinedoesnotimprovemicrocirculatorybloodflowaprospectivestudy
AT kanooreedulvaninas increasingarterialbloodpressurewithnorepinephrinedoesnotimprovemicrocirculatorybloodflowaprospectivestudy
AT palizasfernando increasingarterialbloodpressurewithnorepinephrinedoesnotimprovemicrocirculatorybloodflowaprospectivestudy
AT estenssoroelisa increasingarterialbloodpressurewithnorepinephrinedoesnotimprovemicrocirculatorybloodflowaprospectivestudy
AT incecan increasingarterialbloodpressurewithnorepinephrinedoesnotimprovemicrocirculatorybloodflowaprospectivestudy